Lexeo Therapeutics (LXEO) Non Operating Income (2022 - 2026)
Lexeo Therapeutics (LXEO) reported Non Operating Income of $2.15 million for Q2 2026, down 53.0% from $4.59 million a year earlier but up 0.7% from the prior quarter.
Lexeo Therapeutics (LXEO) Non Operating Income (2022 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Lexeo Therapeutics' Non Operating Income came in at $7.85 million, down 15.1% year-over-year; for FY2025, it was $9.3 million, up 25.1% from FY2024.
- Non Operating Income has increased for three consecutive years, with a three-year compound annual growth rate of 96.1% (FY2022 to FY2025).
- By year, Non Operating Income came in at $7.43 million in FY2024 (+250.8%), $2.12 million in FY2023 (+72.0%) and $1.23 million in FY2022.
- Five-year quarterly Non Operating Income spans a low of $165,000 in Q3 2023 and a high of $4.59 million in Q2 2025.
- Year over year, Non Operating Income gained in four of the last seven quarters, with growth averaging 29.3%.
- The high point for year-over-year Non Operating Income in five years was Q2 2024 (growth of 333.0%); the low point was Q3 2023 (a decline of 61.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $2.14 million (Q1 2026), $2.2 million (Q4 2025) and $1.37 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Lexeo Therapeutics | 265.74 Mn | 265.74 Mn | - | 2.15 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.15 Mn |
| Mar 31, 2026 | 2.14 Mn |
| Dec 31, 2025 | 2.20 Mn |
| Sep 30, 2025 | 1.37 Mn |
| Jun 30, 2025 | 4.59 Mn |
| Mar 31, 2025 | 1.15 Mn |
| Dec 31, 2024 | 1.46 Mn |
| Sep 30, 2024 | 2.05 Mn |
| Jun 30, 2024 | 2.31 Mn |
| Mar 31, 2024 | 1.61 Mn |
| Dec 31, 2023 | 787,000.00 |
| Sep 30, 2023 | 165,000.00 |
| Jun 30, 2023 | 534,000.00 |
| Mar 31, 2023 | 633,000.00 |
| Dec 31, 2022 | 620,000.00 |
| Sep 30, 2022 | 427,000.00 |
Lexeo Therapeutics Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=LXEO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "LXEO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=LXEO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();